Genprex Inc.

12/16/2024 | Press release | Distributed by Public on 12/16/2024 08:15

Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.